Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Diabetic Retinopathy and Vision-Threatening Eye Disease Patients with established diabetic retinopathyparticularly those with severe non-proliferative or proliferative diseaseface potential vision complications from GLP-1 induced rapid glucose lowering
Whistleblower Litigation Aesculap Pays $38.5 Million To Settle FCA Claims Aesculap Implant Systems LLC, a Pennsylvania-based medical device company, has agreed to pay $38.5 million to settle claims that it knowingly sold knee replacement devices that failed at a higher-than-acceptable rate
"Any switch like this should always be done under clinical supervision, since your prescriber needs to work out the right dose for you." Ian Budd, Prescribing Pharmacist at Chemist4U Why would I want to switch treatment
Microbial production of extremolytes High-value active ingredients for nutrition, health care, and well-being
